Fig. 1From: Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancerDistribution of multigene mutations and discordances (EGFR, KRAS, BRAF, HER2 and PIK3CA) in 44 French patients with metastatic non-small-cell lung cancer. The study population was composed of 26 patients sampled at different sites and 18 patients sampled twice at the same primary lung cancer location. Synchronous or metachronous status was taken into account in each groupBack to article page